Erratum: Phase II study of gemcitabine and erlotinib as adjuvant therapy for patients with resected pancreatic cancer (Annals of Surgical Oncology (2011) 18 (1122-1129)DOI: 10.1245/S10434-010-1401-9)

Philip Q. Bao, Ramesh K. Ramanathan, Alyssa Krasinkas, Nathan Bahary, Barry C. Lembersky, David L. Bartlett, Steven J. Hughes, Kenneth K. Lee, A. James Moser, Herbert J. Zeh

Research output: Contribution to journalComment/debatepeer-review

Original languageEnglish (US)
Pages (from-to)S323
JournalAnnals of surgical oncology
Issue numberSUPPL. 3
StatePublished - Dec 2011

ASJC Scopus subject areas

  • Surgery
  • Oncology

Cite this